Skip to main content

Table 2 Costs, health impacts and cost-effectiveness of rotavirus vaccines with comparison to no intervention

From: Correction to: Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option

Strategy Name

Cost

QALYs

Incremental cost-effectiveness ratio ($/QALY)

No vaccine

2379.945

17.71296

(−)

LLR vaccine

2507.851

22.65899

0

Rotarix vaccination

5982.187

24.31454

2105.66

Rotateq vaccination

5577.902

24.44506

1715.14